Nicotine effects on skin: Are they positive or negative

Experimental Dermatology

Volumn 13, Issue 11, 2004, Pages 665-670

  Misery, Laurent ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

Author keywords

Fibroblast; Inflammation; Keratinocytes; Nicotine; Skin

Indexed keywords

NICOTINE; NICOTINE GUM; NICOTINIC RECEPTOR; PYRIDOSTIGMINE;

APHTHOUS ULCER; BEHCET DISEASE; CELL DIFFERENTIATION; CIGARETTE SMOKING; CUTANEOUS PARAMETERS; ERYTHEMA NODOSUM; FIBROBLAST; HUMAN; HYPEREMIA; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; INFLAMMATION; INHIBITION KINETICS; KERATINOCYTE; KIMURA DISEASE; MEDICAL RESEARCH; PEDICULOSIS; PEMPHIGUS VULGARIS; PERIPHERAL NERVOUS SYSTEM; PROTEIN EXPRESSION; PSORIASIS; PYODERMA GANGRENOSUM; REVIEW; SKIN BLOOD VESSEL; SKIN DISEASE; SKIN SURFACE; VASOCONSTRICTION; WOUND HEALING IMPAIRMENT;

AGING; ANIMALS; BLOOD VESSELS; FIBROBLASTS; HUMANS; HYPEREMIA; INFLAMMATION; KERATINOCYTES; NICOTINE; SKIN; SKIN DISEASES; VASOCONSTRICTOR AGENTS; WOUND HEALING;

EID: 8344256524     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2004.00274.x     Document Type: Review

References (69)

1. Krug M, Wunsche A, Blum A. Addiction to tobacco and the consequences for the skin. Hautarzt 2004: 55: 301-315.
2. Kelley A E. Nicotinic receptors: addiction's smoking gun? Nat Med 2002: 8: 447-449.
3. Unwin N. Acetylcholine receptor channel imaged in the open state. Nature 1995: 373: 37-43.
4. MacGehee D S, Role L W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 1995: 57: 521-546.
5. Sgard F, Charpantier E, Bertrand S et al. A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit. Mol Pharmacol 2002: 61: 150-159.
6. Grando S A. Receptor-mediated action of nicotine in human skin. Int J Dermatol 2001: 40: 691-693.
7. Grando S A, Horton R M, Pereira E F R et al. A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed on human keratinocytes. J Invest Dermatol 1995: 105: 774-781.
8. Grando S A, Zelickson B D, Kist D A et al. Keratinocyte muscarinic acetylcholine receptors: immunolocalization and partial characterization. J Invest Dermatol 1995: 104: 95-100.
9. Lang P M, Burgstahler R, Sippel W et al. Characterization of neuronal nicotinic acetylcholine receptors in the membrane of unmyelinated human C-fiber axons by in vitro studies. J Neurophysiol 2003: 90: 3295-3303.
10. Grando S A, Kist D A, Qi M et al. Human keratinocytes synthesize, secrete and degrade acetylcholine. J Invest Dermatol 1993: 101: 32-36.
11. Zia S, Ndoye A, Nguyen V T et al. Nicotine enhances expression of the alpha 3, alpha 4, alpha 5 and alpha 7 nicotinic receptors modultaing calcium metabolism and regulating adhesion and motility of respiratory epithelial cells. Res Commun Mol Pathol Pharmacol 1997: 97: 243-262.
12. Nguyen V T, Ndoye S A, Grando S A. Novel human alpha 9 acetylcholine receptor regulating keratinocyte adhesion is targeted by pemphigus vulgaris autoimmunity. Am J Pathol 2000: 157: 1377-1391.
13. Arredondo J, Nguyen V T, Chernyavsky A I et al. Central role of alpha 7 nicotinic receptor in differentiation of the stratificatious squamous epithelium. J Cell Biol 2002: 159: 325-336.
14. Zia S, Ndoye A, Lee T X et al. Receptor-mediated inhibition of keratinocyte migration by nicotine involves modulations of calcium influx and intracellular concentration. J Pharmacol Exp Ther 2000: 293: 973-981.
15. Nguyen V T, Chernyavsky A I, Arredondo J et al. Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes. Exp Cell Res 2004: 294: 534-549.
16. Nguyen V T, Arredondo J, Chernyavsky A I et al. Keratinocyte acetylcholine receptors regulate cell adhesion. Life Sci 2003: 72: 2081-2085.
17. Grando S A, Horton R M, Mauro T M et al. Activation of keratinocyte nicotinic cholinergic receptors stimulates calcium influx and enhances cell differentiation. J Invest Dermatol 1996: 107: 412-418.
18. Theilig C, Bernd A, Ramirez-Bosca A et al. Reactions of human keratinocytes in vitro after application of nicotine. Skin Pharmacol 1994: 7: 307-315.
19. Kwon O S, Chung J H, Cho K H. Nicotine-enhanced epithelial differentiation in reconstructed human oral mucosa in vitro. Skin Pharmacol Appl Skin Physiol 1999: 12: 227-234.
20. Arredondo J, Nguyen V T, Chernyavsky A I et al. Functional role of alpha 7 nicotinic receptor in physiological control of cutaneous homeostasis. Life Sci 2003: 72: 2063-2067.
21. Nguyen V T, Ndoye A, Hall L L et al. Programmed cell death of keratinocytes culminates in apoptotic secretion of a humectant upon secretagogue action of acetylcholine. J Cell Sci 2001: 114: 1189-1204.
22. Arredondo J, Nguyen V T, Chernyavsky A I et al. A receptor-mediated mechanism of nicotine toxicity in oral keratinocytes. Lab Invest 2001: 81: 1653-1668.
23. Arredondo J, Hall L L, Ndoye A et al. Central role of fibroblast alpha3 nicotinic acetylcholine receptor in mediating cutaneous effects of nicotine. Lab Invest 2003: 83: 207-225.
24. Monfrecola G, Riccio G, Savarese C et al. The acute effect of smoking on cutaneous microcirculation blood flow in habitual smokers and nonsmokers. Dermatology 1998: 197: 115-118.
25. Leow Y H, Maibach H. Cigarette smoking, cutaneous vasculature, and tissue oxygen. Clin Dermatol 1998: 16: 579-584.
26. Conti-Fine B M, Navaneetham D, Lei S et al. Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity? Eur J Pharmacol 2000: 393: 279-294.
27. Mavropoulos A, Aars H, Brodin P. Hyperaemic response to cigarette smoking in healthy gingiva. J Clin Periodontol 2003: 30: 214-221.
28. Kirkpatrick C J, Bittinger F, Nozadze K et al. Expression and function of the non-neuronal cholinergic system in endothelial cells. Life Sci 2003: 72: 2111-2116.
29. Black C E, Huang N, Neligan P C et al. Effect of nicotine on vasoconstrictor and vasodilator responses in human skin vasculature. Am J Physiol Regul Integr Comp Physiol 2001: 281: 1097-1104.
30. Miao F J, Green P G, Benowitz N et al. Central terminals of nociceptors are targets for nicotine suppression of inflammation. Neuroscience 2004: 123: 777-784.
31. Lotti N, MacCusker E J, Campbell A. Nicotine is chemotactic for neutrophils and enhances neutrophil responsiveness to chemotactic peptides. Science 1984: 223: 169-171.
32. Sasagawa S, Suzuki K, Sakatain T. Effects of nicotine on the functions of human polymorphonuclear leukocytes in vitro. J Leukoc Biol 1985: 37: 493-502.
33. Wang H, Yu M, Ochani M et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003: 421: 384-388.
34. Sopori M L, Kozak W, Savage S M et al. Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology 1998: 23: 189-204.
35. Mils C. Cigarette smoking, cutaneous immunity, and inflammatory response. Clin Dermatol 1998: 16: 589-594.
36. Müller P, Imhof P R, Mauli D. Human pharmacological investigations of a transdermal nicotine system. Method Find. Exp Clin Pharmacol 1989: 197-204.
37. Dussor G O, Leong A S, Gracia N B et al. Potentiation of evoked calcitonin gene-related peptide release from oral mucosa: a potential basis for the pro-inflammatory effects of nicotine. Eur J Neurosci 2003: 18: 2515-2526.
38. Hosoi J, Murphy G F, Egan C L et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993: 363: 159-163.
39. Chang Y C, Tsai C H, Yang S H et al. Induction of cyclooxygenase-2 mRNA and protein expression in human gingival fibroblasts stimulated with nicotine. J Periodontol Res 2003: 38: 496-501.
40. Johnson G K, Organ C C. Prostaglandin E2 and interleukin-1 concentrations in nicotine-exposed oral keratinocyte cultures. J Periodontol Res 1997: 32: 447-454.
41. Eliakim R, Karmeli F. Divergent effects of nicotine administration on cytokine levels in rat small bowel mucosa, colonic mucosa, and blood. Isr Med Assoc J 2003: 5: 178-180.
42. Denda M, Fuziwara S, Inoue K. Influx of calcium and chloride ions into epidermal keratinocytes regulates exocytosis of epidermal lamellar bodies and skin permeability barrier homeostasis. J Invest Dermatol 2003: 121: 362-367.
43. Wong L S, Green H M, Feugate J E et al. Effects of 'second-hand' smoke on structure and function of fibroblasts, cells that are critical for tissue repair and remodeling. BMC Cell Biol 2004: 5: 13.
44. Campanile G, Hautmann G, Lotti T. Cigarette smoking, wound healing, and face-lift. Clin Dermatol 1998: 16: 575-578.
45. Silverstein P. Smoking and wound healing. Am J Med 1992: 93: 22S-4S.
46. Jacobi J, Jang J J, Sundram U et al. Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol 2002: 161: 97-104.
47. Anuradha V, Gore V, Chien Y W. The nicotine transdermal system. Clin Dermatol 1998: 16: 599-615.
48. Murphy M, Carmichael A J. Transdermal drug delivery systems and skin sensitivity reactions. Am J Clin Dermatol 2000: 1: 361-368.
49. Lee I W, Ahn S K, Choi E H et al. Urticarial reaction following the inhalation of nicotine in tobacco smoking. Br J Dermatol 1998: 138: 486-488.
50. Kramer U, Lemmen C H, Behrendt H et al. The effect of environmental tobacco smoke on eczema and allergic sensitization in children. Br J Dermatol 2004: 150: 111-118.
51. Naldi L. Cigarette smoking and psoriasis. Clin Dermatol 1998: 16: 571-574.
52. Rahier S, Piérard-Franchimont C, Pierard G E. La peau du sujet tabagique. Rev Med Liege 1996: 51: 582-585.
53. Heeschen C, Jang J J, Weis M. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001: 7: 833-839.
54. Myles M E, Alack C, Manino P M et al. Nicotine applied by transdermal patch induced HSV-1 reactivation and ocular shedding in latently infected rabbits. J Ocul Pharmacol Ther 2003: 19: 121-133.
55. Axell T, Liedholm R. Occurrence of recurrent herpes labialis in an adult Swedish population. Acta Odontol Scand 1990: 48: 119-123.
56. Inaloz H S, Inaloz S S, Deveci E et al. Teratogenic effects of nicotine on rat skin. Clin Exp Obstet Gynecol 2000: 27: 241-243.
57. Hagforsen E, Edvinsson M, Nordlind K et al. Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis. Br J Dermatol 2002: 146: 383-391.
58. Davies P, Levy S, Pahari A et al. Acute nicotine poisoning associated with a traditional remedy for eczema. Arch Dis Child 2001: 85: 500-502.
59. Grando S A. Autoimmunity to keratinocyte acetylcholine receptors in pemphigus. Dermatology 2000: 201: 290-295.
60. Grando S A. New approaches to the treatment of pemphigus. J Investig Dermatol Symp Proc 2004: 9: 84-91.
61. Nguyen V T, Arredondo J, Chernyavsky A I et al. Pemphigus vulgaris acantholysis ameliorated by cholinergic agonists. Arch Dermatol 2004: 140: 327-334.
62. Mehta J N, Martin A G. A case of pemphigus vulgaris improved by cigarette smoking. Arch Dermatol 2000: 136: 15-17.
63. Kanekura T, Uchino Y, Kanzaki T. A case of malignant atrophic papulosis successfully treated with nicotine patches. Br J Dermatol 2003: 149: 660-662.
64. Kanekura T, Usuki K, Kanzaki T. Skin disorders with prominent eosinophilic infiltration treated successfully with nicotine. Report of two cases. Dermatology 2004: 208: 153-157.
65. Kanekura T, Usuki K, Kanzaki T. Nicotine for pyoderma gangrenosum. Lancet 1995: 345: 1058.
66. Kanekura T, Kanzaki T. Successful treatment of orogenital ulceration with transdermal nicotine patches. Br J Dermatol 1999: 141: 1140-1141.
67. Wolf R, Wolf D, Ruocco V. The benefits of smoking in skin diseases. Clin Dermatol 1998: 16: 641-647.
68. Bittoun R. Recurrent aphthous ulcers and nicotine. Med J Aust 1991: 154: 471-472.
69. Burkhart C G, Burkhart C N. Use of topical nicotine for treatment of Pediculus humanis capitis. J Med Entomol 2000: 37: 170-171.